...
机译:进一步的证据表明可溶性尿激酶纤溶酶原激活剂受体不直接损伤小鼠或人的泛细胞
Univ Calif San Francisco Dept Pharmaceut Chem San Francisco CA USA;
Univ Calif San Francisco Kidney Transplant Serv San Francisco CA 94143 USA;
AbbVie Renal Discovery Chicago IL USA;
AbbVie Renal Discovery Chicago IL USA;
Univ Calif San Francisco Kidney Transplant Serv San Francisco CA 94143 USA;
AbbVie Renal Discovery Chicago IL USA;
Univ Calif San Francisco Kidney Transplant Serv San Francisco CA 94143 USA;
Univ Calif San Francisco Kidney Transplant Serv San Francisco CA 94143 USA;
Univ Calif San Francisco Helen Diller Family Comprehens Canc Ctr San Francisco CA 94143 USA;
Univ Calif San Francisco Div Transplant Surg San Francisco CA 94143 USA;
Univ Calif San Francisco Dept Pharmaceut Chem San Francisco CA USA;
Univ Calif San Francisco Kidney Transplant Serv San Francisco CA 94143 USA;
机译:进一步的证据表明可溶性尿激酶纤溶酶原激活剂受体不直接损伤小鼠或人的泛细胞
机译:霍奇金淋巴瘤患者尿激酶纤溶酶原激活物受体,可溶性尿激酶纤溶酶原激活物受体和β1整合素的评估
机译:可溶性尿激酶型纤溶酶原激活剂受体和尿激酶型纤溶酶原激活剂受体有助于白血病中的化学化
机译:抑制肿瘤相关的尿激酶型纤溶酶原激活系统:高水平合成在体外和体内卵巢癌细胞中可溶性尿激酶受体的影响
机译:尿激酶纤溶酶原激活物受体在人胸膜恶性间皮瘤中的作用
机译:反复进行血浆置换并同时监测可溶性尿激酶型纤溶酶原激活物受体介导的足细胞β3-整合素激活可治疗复发性原发灶性局部节段性肾小球硬化
机译:加强血浆交换和可溶性尿激酶型纤溶酶原激活剂受体介导的泛骨细胞β3-整合素激活的复发初级焦平肾小球粥样硬化